Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...
Cronos Group CRON continues to attract investor attention as the cannabis company strengthens its global footprint and ...
Cronos Group recently expanded its share repurchase program after the Toronto Stock Exchange approved its notice, allowing the company to buy back up to US$50,000,000 of common shares on both U.S. and ...
For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...
Investors are clamoring to invest in publicly-traded cannabis companies as the legal marijuana market expands. Despite the clear growth potential in this industry, investors still need to exercise ...
Cronos Group Inc (NASDAQ:CRON) reported first-quarter financial results ahead of the market open Thursday. Here’s a look at the key highlights from the cannabis company’s report. Q1 Revenue: Cronos ...
Hosted on MSN
Cronos signals revenue boost potential with 70% flower capacity increase amid international momentum
Earnings Call Insights: Cronos Group Inc. (CRON:CA) Q3 2025 Michael Gorenstein, President, CEO & Chairman, stated that "Cronos delivered another record quarter in Q3 2025, underscoring the continued ...
Cronos (CRON) fell ~5% in the premarket on Thursday after the Canadian cannabis player reported better-than-expected revenue for Q4 2025 while indicating a quarterly net loss primarily due to ...
Cronos Group Inc (NASDAQ:CRON) shares are trading lower by 2.78% to $2.63 during Tuesday’s session. Shares of cannabis stocks are trading lower in sympathy with Tilray, which fell after reporting ...
Altria Group Inc. said Monday it will continue to evaluate prospects of cannabis company Cronos Group Inc. on whether it will acquire additional common shares of Cronos or dispose of them in the open ...
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Thursday, June 18, 2026 (the “Meeting”), shareholders ...
Why does the DEA date matter for Cronos Group? At first glance, when the DEA holds its public meeting about rescheduling cannabis might not seem to matter to Cronos Group. The company doesn't sell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results